Sessile serrated adenomas and classical adenomas: An epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract

The diagnosis of sessile serrated adenomas (SSAs) is challenging, and there is a great deal of interobserver variability amongst pathologists in differentiating SSAs from hyperplastic polyps (HPPs). The aim of this study was (i) to assess the utility of epigenetic changes such as DNA methylation in differentiating SSAs from HPPs and (ii) to identify common methylation based molecular markers potentially useful for early detection of premalignant neoplastic lesions of gastrointestinal tract. A total of 97 primary patient adenoma samples were obtained from The Johns Hopkins Hospital pathology archive with IRB approval and HIPAA compliance. We analyzed the promoter associated CpG island methylation status of 17 genes using nested multiplex methylation specific PCR (MSP). Methylation of CDX2, hMLH1 and TLR2 was detected in SSAs and SSAs with dysplasia but not in HPPs. A subset of genes including EVL, GATAs (4 and 5), HIN‐1, SFRPs (1, 2, 4 and 5), SOX17 and SYNE1 were methylated frequently in all premalignant gastrointestinal adenomas including tubular adenomas, villous adenomas, SSAs and SSAs with dysplasia but infrequently in non‐premalignant polyps such as HPPs. Methylation of CDX2, hMLH1 and TLR2 may be of diagnostic utility in differentiating, histologically challenging cases of SSAs from HPPs. Genes such as EVL, GATAs, HIN‐1, SFRPs, SOX17 and SYNE1, which are frequently methylated in all types of tested premalignant adenomas, may be useful as biomarkers in stool‐based strategies for early detection of these adenomas and CRCs in future.

[1]  E. Montgomery,et al.  Beta-catenin Nuclear Labeling is a Common Feature of Sessile Serrated Adenomas and Correlates With Early Neoplastic Progression After BRAF Activation , 2009, The American journal of surgical pathology.

[2]  J. Herman,et al.  Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. , 2008, Cancer research.

[3]  E. Montgomery,et al.  Frequent beta-catenin nuclear labeling in sessile serrated polyps of the colorectum with neoplastic potential. , 2008, American journal of clinical pathology.

[4]  David K. Driman,et al.  Sessile Serrated Adenoma (SSA) vs. Traditional Serrated Adenoma (TSA) , 2008, The American journal of surgical pathology.

[5]  Mari Mino-Kenudson,et al.  Sessile Serrated Adenoma: Challenging Discrimination From Other Serrated Colonic Polyps , 2008, The American journal of surgical pathology.

[6]  J. Herman,et al.  Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter , 2007, Oncogene.

[7]  T. Uehara,et al.  Hyperplastic polyps and sessile serrated ‘adenomas’ of the colon and rectum display gastric pyloric differentiation , 2007, Histochemistry and Cell Biology.

[8]  H. Hermeking,et al.  DNA Stool Test for Colorectal Cancer: Hypermethylation of the Secreted Frizzled-Related Protein-1 Gene , 2007, Diseases of the colon and rectum.

[9]  Wei Chen,et al.  Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal Cancer , 2007, PLoS genetics.

[10]  M. Mäkinen,et al.  Colorectal serrated adenocarcinoma , 2007, Histopathology.

[11]  P. Laird,et al.  CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.

[12]  N. Goldstein.  Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. , 2006, American journal of clinical pathology.

[13]  K. Batts,et al.  Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. , 2005, American journal of clinical pathology.

[14]  J. Jass.  Serrated adenoma of the colorectum and the DNA-methylator phenotype , 2005, Nature Clinical Practice Oncology.

[15]  M. Mäkinen,et al.  The risk of metachronous neoplasia in patients with serrated adenoma. , 2005, American journal of clinical pathology.

[16]  S. Toyooka,et al.  Aberrant methylation of HIN‐1 (high in normal‐1) is a frequent event in many human malignancies , 2005, International journal of cancer.

[17]  E. J. Lee,et al.  Progressive methylation during the serrated neoplasia pathway of the colorectum , 2005, Modern Pathology.

[18]  M. Washington,et al.  Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  M. O'brien,et al.  BRAF and KRAS Mutations in Hyperplastic Polyps and Serrated Adenomas of the Colorectum: Relationship to Histology and CpG Island Methylation Status , 2004, The American journal of surgical pathology.

[20]  B. Leggett,et al.  Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer , 2004, Gut.

[21]  K. Kaneko,et al.  No major tumorigenic role for β-catenin in serrated as opposed to conventional colorectal adenomas , 2003, British Journal of Cancer.

[22]  R Alexandra Goldbohm,et al.  Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. , 2003, Cancer research.

[23]  N. Goldstein,et al.  Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. , 2003, American journal of clinical pathology.

[24]  Tsung-Teh Wu,et al.  Frequent CpG island methylation in serrated adenomas of the colorectum. , 2003, The American journal of pathology.

[25]  Jahn M. Nesland,et al.  Morphologic Reappraisal of Serrated Colorectal Polyps , 2003, The American journal of surgical pathology.

[26]  B. Leggett,et al.  Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer. , 2002, Cancer research.

[27]  B. Leggett,et al.  Emerging concepts in colorectal neoplasia. , 2002, Gastroenterology.

[28]  K. Kinzler,et al.  Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status , 2002, Nature.

[29]  E. Sawyer,et al.  Molecular characteristics of serrated adenomas of the colorectum , 2002, Gut.

[30]  R. Ward,et al.  CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. , 2002, Gastroenterology.

[31]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[32]  R. Ward,et al.  Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. , 2001, Journal of the National Cancer Institute.

[33]  Jeffrey S. Morris,et al.  CpG island methylation in colorectal adenomas. , 2001, The American journal of pathology.

[34]  J. Jass.  Serrated route to colorectal cancer: back street or super highway? , 2001, The Journal of pathology.

[35]  J. Herman,et al.  Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. , 2000, Cancer research.

[36]  J. Herman,et al.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. , 2000, Cancer research.

[37]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[38]  N. Ahuja,et al.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Herman,et al.  Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. , 2000, Cancer research.

[40]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Baylin,et al.  Aging and DNA methylation in colorectal mucosa and cancer. , 1998, Cancer research.

[42]  J. Herman,et al.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  H. Toda,et al.  Genetic Alterations of Mixed Hyperplastic Adenomatous Polyps in the Colon and Rectum , 1998, Japanese journal of cancer research : Gann.

[44]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Torlakovic,et al.  Serrated adenomatous polyposis in humans. , 1996, Gastroenterology.

[46]  C. Fenoglio-Preiser,et al.  Mixed Hyperplastic Adenomatous Polyps/Serrated Adenomas: A Distinct Form of Colorectal Neoplasia , 1990, The American journal of surgical pathology.

[47]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[48]  J. Jass,et al.  A morphologic and histochemical study of metaplastic polyps of the colorectum , 1984, Cancer.

[49]  H. Goldman,et al.  Nature and significance of hyperplastic polyps of the human colon. , 1970, Archives of pathology.